AstraZeneca bets on new cancer treatments with $2 bln Fusion Pharma purchase – ET HealthWorld | Pharma
By Yadarisa Shabong London: AstraZeneca said on Tuesday it will buy clinical-stage biopharmaceutical company Fusion Pharmaceuticals Inc for about $2 billion in cash as the...